About NEUWAY PharmaNEUWAY: focuses on the preclinical and clinical development of innovative therapeutics for treatment of severe orphan brain diseases based on its proprietary CNS Drug Delivery Platform.
Founder and CEO: Stephan Rapp
Founder and CSO: Heiko Manninga
COO: Rudi Scherhag
5 articles about NEUWAY Pharma
NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive Officer and Dr Thomas Christoph as Chief Development Officer
NEUWAY Pharma GmbH announced two new appointments in its senior leadership team: Dr Oliver Ernst, formerly NEUWAY's Chief Operating Officer, was promoted to Chief Executive Officer, and Dr Thomas Christoph was appointed as new Chief Development Officer.
NEUWAY Pharma GmbH announced the appointment of Dr Jacques Mallet as an additional independent member of the Advisory Board.
7/9/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
NEUWAY Pharma announced the formation of its Scientific Advisory Board including leading drug delivery and drug development experts Hans Grünhagen, Olaf Ritzeler, and Georg Terstappen.
NEUWAY Pharma And Cobra Biologics Ltd. Collaborate To Develop GMP Grade Engineered Protein Capsules (EPCs) Manufacturing Process